Immunotherapy through TCR gene transfer

The antigen specificity of T lymphocytes is dictated solely by the T cell receptor (TCR) α and β chains. Consequently, genetic transfer of TCR chains may be an appealing strategy with which to impose a desirable virus- or tumor-antigen specificity onto cytotoxic or helper T cell populations. We describe here the genetic introduction of a virus-specific TCR into peripheral T cells in a mouse model system. These experiments showed that T cells redirected by TCR gene transfer expanded upon viral infection of mice and efficiently homed to effector sites. In this setting, TCR gene transfer was not associated with any significant autoimmune pathology. In addition, small numbers of TCR-transduced T cells promoted the rejection of antigen-expressing tumors in vivo. These data suggest that the redirection of T cells by TCR gene transfer is a viable strategy for the rapid induction of virus- or tumor-specific immunity.

[1]  T N Schumacher,et al.  Changing T cell specificity by retroviral T cell receptor display. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[2]  T. Kitamura,et al.  New experimental approaches in retrovirus-mediated expression screening. , 1998, International journal of hematology.

[3]  A Ferrant,et al.  Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. , 1995, Blood.

[4]  J. Davey,et al.  Cytotoxic T cells recognize fragments of the influenza nucleoprotein , 1985, Cell.

[5]  T. Heikkinen,et al.  Increasing importance of viruses in acute otitis media , 2000, Annals of medicine.

[6]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[7]  B. Groner,et al.  Adoptive transfer of in vitro-targeted, activated T lymphocytes results in total tumor regression. , 1997, Journal of immunology.

[8]  P. Harrison.  An ethanol-acetic acid-formol saline fixative for routine use with special application to the fixation of non-perfused rat lung , 1984, Laboratory animals.

[9]  J. Altman,et al.  Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. , 1998, Immunity.

[10]  P. Grufman,et al.  Superdominance among immunodominant H-2Kb-restricted epitopes and reversal by dendritic cell-mediated antigen delivery. , 1998, Journal of immunology.

[11]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[12]  H. V. van Houwelingen,et al.  Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. , 1996, The New England journal of medicine.

[13]  R. Ahmed,et al.  Costimulation in antiviral immunity: differential requirements for CD4(+) and CD8(+) T cell responses. , 2000, Current opinion in immunology.

[14]  D. Kohn,et al.  Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Kitamura,et al.  Functional Reconstitution of Class II MHC-Restricted T Cell Immunity Mediated by Retroviral Transfer of the αβ TCR Complex1 , 2000, The Journal of Immunology.

[16]  Robert H. Collins,et al.  Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  B. Groner,et al.  Growth retardation of tumors by adoptive transfer of cytotoxic T lymphocytes reprogrammed by CD44V6‐specific SCFV: ζ‐chimera , 1996, International journal of cancer.

[18]  Alexis M. Kalergis,et al.  Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex , 2001, Nature Immunology.

[19]  E. Palmer,et al.  A motif within the T cell receptor α-chain constant region connecting peptide domain controls antigen responsiveness , 1997 .

[20]  J. McCubrey,et al.  Transfer of specificity by murine α and β T-cell receptor genes , 1986, Nature.

[21]  N. Mueller.  Overview of the epidemiology of malignancy in immune deficiency. , 1999, Journal of acquired immune deficiency syndromes.

[22]  H. Heslop,et al.  Adoptive cellular immunotherapy for EBV lymphoproliferative disease. , 1997, Immunological reviews.

[23]  D. Kohn,et al.  Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Michel Sadelain,et al.  Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin , 2000, Nature.

[25]  T. Schumacher,et al.  Systemic T cell expansion during localized viral infection , 1999, European journal of immunology.

[26]  R. Schreiber,et al.  IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.

[27]  P. Gorer.  Studies in Antibody Response of Mice to Tumour Inoculation , 1950, British Journal of Cancer.

[28]  W. Murphy,et al.  New strategies for preventing graft-versus-host disease. , 1999, Current opinion in immunology.

[29]  J W Gratama,et al.  Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR , 2000, Gene Therapy.

[30]  E. Palmer,et al.  Defective Signaling to Fyn by a T Cell Antigen Receptor Lacking the α-Chain Connecting Peptide Motif* , 2001, The Journal of Biological Chemistry.

[31]  Rudolf Jaenisch,et al.  De novo methylation and expression of retroviral genomes during mouse embryogenesis , 1982, Nature.

[32]  S. Rosenberg,et al.  Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. , 1999, Journal of immunology.

[33]  M. Kalos,et al.  Transfer of Specificity for Human Immunodeficiency Virus Type 1 into Primary Human T Lymphocytes by Introduction of T-Cell Receptor Genes , 2000, Journal of Virology.

[34]  J. Altman,et al.  Characteristics of virus-specific CD8(+) T cells in the liver during the control and resolution phases of influenza pneumonia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Antonio Lanzavecchia,et al.  T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds , 1996, Science.

[36]  H. Heslop,et al.  Adoptive cellular immunotherapy for EBV lymphoproliferative diseases , 1997 .

[37]  Gorer Pa.  Studies in antibody response of mice to tumour inoculation. , 1950 .

[38]  D. Busch,et al.  T Cell Affinity Maturation by Selective Expansion during Infection , 1999, The Journal of experimental medicine.

[39]  J. Wells,et al.  Stable heterodimers from remodeling the domain interface of a homodimer using a phage display library. , 1997, Journal of molecular biology.

[40]  E. Palmer,et al.  A motif within the T cell receptor alpha chain constant region connecting peptide domain controls antigen responsiveness. , 1996, Immunity.

[41]  W. Glezen.  Prevention of acute otitis media by prophylaxis and treatment of influenza virus infections. , 2000, Vaccine.

[42]  K D Wittrup,et al.  In vitro evolution of a T cell receptor with high affinity for peptide/MHC. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Hans J. Stauss,et al.  Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer , 2001, Nature Immunology.